drugset / Trial / NCT03742908

Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients

NCT03742908

RandomizedParallel-groupOpen-labelPrevention

Summary

The study aims to investigate different approaches of local application of antibiotics/antiseptics intraoperatively in Chinese patients undergoing post-mastectomy implant based breast reconstruction, and aims to single out an intervention method that limits the use of antibiotics and maintains low rates of surgical site infection and capsular contracture. Patients who undergo post mastectomy breast reconstruction in the breast reconstruction department in Tianjin Medical University Cancer Institute and Hospital are eligible to enter the study.

Timeline

Start
2018-06-16
Primary completion
2021-10-31
Completion
2021-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefazolin Small molecule 200 mg Other
Subject Clindamycin Unknown 600 mg Other

Indications